Subject: engineering their oligosaccharide component biol. One way to obtain large increases in potency, while maintaining a simple production process and potentially avoiding significant, undesirable side effects, is to enhance the natural, cell-mediated effector functions of monoclonal antibodies by engineering their oligosaccharide component as described in Umana, P., et al., помогите, пожалуйста, нормально перевести: Спасибо заранее! |
You need to be logged in to post in the forum |